Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−37.88 M USD
2.20 M USD
1.08 M
About Seelos Therapeutics, Inc.
Sector
Industry
CEO
Raj Mehra
Website
Headquarters
New York
Founded
1987
FIGI
BBG000BZ9W18
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of SEELQ is 0.0005 USD — it hasn't changed in the past 24 hours. Watch Seelos Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Seelos Therapeutics, Inc. stocks are traded under the ticker SEELQ.
SEELQ stock hasn't changed in a week, the last month showed zero change in price, over the last year Seelos Therapeutics, Inc. has showed a −100.00% decrease.
SEELQ reached its all-time high on Jan 13, 2010 with the price of 1,676,651,190,123.0258 USD, and its all-time low was 0.000001 USD and was reached on Feb 11, 2025. View more price dynamics on SEELQ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SEELQ stock is 0.00% volatile and has beta coefficient of −1.26. Track Seelos Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Seelos Therapeutics, Inc. there?
Yes, you can track Seelos Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Seelos Therapeutics, Inc. is going to release the next earnings report on May 2, 2025. Keep track of upcoming events with our Earnings Calendar.
No, SEELQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 2, 2025, the company has 16 employees. See our rating of the largest employees — is Seelos Therapeutics, Inc. on this list?
Like other stocks, SEELQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Seelos Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Seelos Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Seelos Therapeutics, Inc. stock shows the sell signal. See more of Seelos Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.